Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of MenACWY-CRM in Healthy Children 12-59 Months
NCT00310817Phase 2Completed
- Sponsor
- Novartis
- Start
- Mar 2005
- Primary completion
- May 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of Meningococcal A, C, Y and W-135 conjugate vaccine in meningococcal meningitis, sponsored by Novartis. Started Mar 2005; status: completed.
02
Drugs
Meningococcal A, C, Y and W-135 conjugate vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT00310817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310817.